← All organizations

Inhibitex

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 9, 2005

Acquired by Bristol-Myers Squibb on Jan 1, 2012

Timeline

1990s

Jan 1, 1994
Inhibitex— Founded

2010s

Jan 1, 2012
Bristol-Myers Squibb— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

tefibazumab

Other trials (1 own, 0 via acquisition)

veronate

Indications

Studied for

Recent trials (3)

NCT00198302Study directorPhase 2Sep 9, 2005
NCT00198289Study directorPhase 2Apr 1, 2005
NCT00113191Study directorN/AMay 1, 2004

Details

Founded: Alpharetta, GA, US Jan 1, 1994
Last known activity: Sep 9, 2005